Fall Leadership for Drug Development Teams

October 6, 13, 20, 27 | 12-4pm ET

About this Course

This highly interactive online course, offered twice each year, brings together team leaders, program managers, functional directors, and other drug development professionals from across the industry to build leadership skills, improve cross-functional performance, and enhance R&D productivity. Delegates meet online in large and small groups over the course of four weeks. 

Created specifically for pharmaceutical professionals, the program uses case studies to teach you how to lead multi-disciplinary teams and to collaborate effectively in managing complex challenges in pharmaceutical R&D. New program material has been incorporated to focus on how remote teams can operate effectively and productively. We will examine solutions and strategies for getting the most out of remote teams including creating and maintaining high levels of engagement, improving communications, sustaining motivation, establishing and measuring performance, and conducting more productive team meetings in a distributed environment.

Tufts CSDD holds the Leadership for Drug Development Teams course several times each year. Custom programs are also available for professionals within a single organization.

Earn a Digital Badge!

  • Showcase the knowledge and skills you acquired from the program.
  • Share your learning achievements with clients, employers, and colleagues on online platforms and social media networks like LinkedIn, Facebook and Twitter.
“I was able to immediately make improvements after taking this course…Once others started seeing the way I interacted, I noticed that they mirrored the behavior. It’s made a difference in the team.” Program Manager, Sanofi
“I really appreciate that it was drug-development focused. The examples were so close to our real lives that it made them easy to implement. The course was perfectly suited to my professional development goals: to develop the skills I need for integrated work in a matrix organization.” Clinical Research Physician, AstraZeneca
“I enjoyed the workshop tremendously. The topics were relevant and coherent and the group interactions gave me many different perspectives. I am eager to practice the skills in real life.” Principal Scientist, Immuno



Sponsor/Academic/Non-profit/Gov’t* Rate


Alumni Rate


*To inquire about group rates, please email csdd@tufts.edu

Course Facilitators

Robert Franco, PhD

Course Facilitator President, Coe Point Associates LLC

With over 24 years of consulting experience, Dr. Franco led PwC’s Pharmaceutical R&D practice where he specialized in improving pharmaceutical drug development, technology transfer, clinical trial operations, and manufacturing. Dr. Franco has worked with the senior management of several large pharmaceutical and biotechnology companies, NGOs, and multinational organizations to implement complex change management initiatives to improve growth, reduce costs, and remediate quality and regulatory issues. Dr. Franco has eight management consulting articles, 13 technical publications, and three patents to his name and has served on several international technical review and regulatory standards committees. He has a Doctor of Philosophy and Master of Science in biochemistry from the University of Rochester.

Kenneth Kaitin, PhD

Professor of Medicine and Senior Fellow

Kenneth Kaitin is Professor and Senior Fellow at Tufts Center for the Study of Drug Development at Tufts University School of Medicine. He previously served as the group’s Director for 23 years. He is also an Advisory Professor at Shanghai Medical College at Fudan University, and he serves on the faculties of the European Center for Pharmaceutical Medicine at the University of Basel, and the American Course on Drug Development and Regulatory Science at the University of California, San Francisco. Dr. Kaitin is recognized internationally for his contributions in the fields of drug development policy and science. He consults, speaks, and writes on global trends in pharmaceutical development and regulation, and he has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, Dr. Kaitin recently served as Editor-in-Chief of Expert Review of Clinical Pharmacology,and as a consultant to the U.S. Department of Defense on bioterror countermeasures. In 2011, he received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators, in 2020 he was named Global Fellow in Medicines Development by the International Federation of Pharmaceutical Physicians, and in 2021 he received the Distinguished Achievement Award from the Sino-American Pharmaceutical Professionals Association (SAPA). Dr. Kaitin is a director on the boards of Curis, Inc. (NASDAQ: CRIS), Bio-Tree Systems, Inc., and QCDx LLC. He earned his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.


Have any questions? Enter your information below to get in touch with our enrollment team. 

Ready to enroll?